Eyenovia Inc (NASDAQ: EYEN) kicked off on Friday, down -5.15% from the previous trading day, before settling in for the closing price of $0.07. Over the past 52 weeks, EYEN has traded in a range of $0.06-$2.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 125.00%. While this was happening, its average annual earnings per share was recorded 6.06%. With a float of $109.77 million, this company’s outstanding shares have now reached $111.42 million.
Let’s determine the extent of company efficiency that accounts for 57 employees. In terms of profitability, gross margin is -4716.41%, operating margin of -109178.31%, and the pretax margin is -118845.16%.
Eyenovia Inc (EYEN) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Eyenovia Inc is 1.49%, while institutional ownership is 11.96%. The most recent insider transaction that took place on Aug 28 ’24, was worth 14,077. In this transaction Chief Executive Officer of this company bought 27,071 shares at a rate of $0.52, taking the stock ownership to the 109,998 shares. Before that another transaction happened on Aug 26 ’24, when Company’s Chief Executive Officer bought 50,000 for $0.57, making the entire transaction worth $28,500. This insider now owns 82,927 shares in total.
Eyenovia Inc (EYEN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.06% per share during the next fiscal year.
Eyenovia Inc (NASDAQ: EYEN) Trading Performance Indicators
Take a look at Eyenovia Inc’s (EYEN) current performance indicators. Last quarter, stock had a quick ratio of 0.53. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 232.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.73, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of Eyenovia Inc (EYEN)
Looking closely at Eyenovia Inc (NASDAQ: EYEN), its last 5-days average volume was 29.73 million, which is a drop from its year-to-date volume of 38.28 million. As of the previous 9 days, the stock’s Stochastic %D was 4.12%. Additionally, its Average True Range was 0.02.
During the past 100 days, Eyenovia Inc’s (EYEN) raw stochastic average was set at 0.44%, which indicates a significant decrease from 1.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 266.77% in the past 14 days, which was higher than the 241.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1562, while its 200-day Moving Average is $0.5780. However, in the short run, Eyenovia Inc’s stock first resistance to watch stands at $0.0677. Second resistance stands at $0.0729. The third major resistance level sits at $0.0767. If the price goes on to break the first support level at $0.0587, it is likely to go to the next support level at $0.0549. Should the price break the second support level, the third support level stands at $0.0497.
Eyenovia Inc (NASDAQ: EYEN) Key Stats
The company with the Market Capitalisation of 6.98 million has total of 111,425K Shares Outstanding. Its annual sales at the moment are 4 K in contrast with the sum of -27,260 K annual income. Company’s last quarter sales were recorded 20 K and last quarter income was -11,050 K.
